nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2A—Methyltestosterone—Prednisone—psoriatic arthritis	0.0106	0.506	CbGdCrCtD
Dexrazoxane—TOP2A—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0103	0.494	CbGdCrCtD
Dexrazoxane—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.0055	0.00561	CcSEcCtD
Dexrazoxane—Nausea—Auranofin—psoriatic arthritis	0.00547	0.00559	CcSEcCtD
Dexrazoxane—Oesophagitis—Prednisone—psoriatic arthritis	0.00546	0.00558	CcSEcCtD
Dexrazoxane—Sepsis—Prednisone—psoriatic arthritis	0.00519	0.0053	CcSEcCtD
Dexrazoxane—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00495	0.00506	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00483	0.00494	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.00479	0.00489	CcSEcCtD
Dexrazoxane—Sepsis—Methotrexate—psoriatic arthritis	0.00434	0.00443	CcSEcCtD
Dexrazoxane—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00422	0.00431	CcSEcCtD
Dexrazoxane—Infestation—Methylprednisolone—psoriatic arthritis	0.00422	0.00431	CcSEcCtD
Dexrazoxane—Haemoglobin—Prednisolone—psoriatic arthritis	0.00415	0.00424	CcSEcCtD
Dexrazoxane—Haemorrhage—Prednisolone—psoriatic arthritis	0.00413	0.00422	CcSEcCtD
Dexrazoxane—Weight decreased—Betamethasone—psoriatic arthritis	0.0039	0.00398	CcSEcCtD
Dexrazoxane—Weight decreased—Dexamethasone—psoriatic arthritis	0.0039	0.00398	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00383	0.00391	CcSEcCtD
Dexrazoxane—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00382	0.0039	CcSEcCtD
Dexrazoxane—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00381	0.00389	CcSEcCtD
Dexrazoxane—Haemorrhage—Triamcinolone—psoriatic arthritis	0.0038	0.00388	CcSEcCtD
Dexrazoxane—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00379	0.00387	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00373	0.00381	CcSEcCtD
Dexrazoxane—Erythema—Prednisolone—psoriatic arthritis	0.0036	0.00367	CcSEcCtD
Dexrazoxane—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00352	0.00359	CcSEcCtD
Dexrazoxane—Neutropenia—Prednisone—psoriatic arthritis	0.00351	0.00358	CcSEcCtD
Dexrazoxane—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00347	0.00354	CcSEcCtD
Dexrazoxane—Haemoglobin—Betamethasone—psoriatic arthritis	0.00347	0.00354	CcSEcCtD
Dexrazoxane—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00345	0.00352	CcSEcCtD
Dexrazoxane—Haemorrhage—Betamethasone—psoriatic arthritis	0.00345	0.00352	CcSEcCtD
Dexrazoxane—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00344	0.00351	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00342	0.00349	CcSEcCtD
Dexrazoxane—Weight decreased—Prednisone—psoriatic arthritis	0.00339	0.00347	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00334	0.00341	CcSEcCtD
Dexrazoxane—Depression—Prednisone—psoriatic arthritis	0.00334	0.00341	CcSEcCtD
Dexrazoxane—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00332	0.00339	CcSEcCtD
Dexrazoxane—Erythema—Triamcinolone—psoriatic arthritis	0.00331	0.00338	CcSEcCtD
Dexrazoxane—Erythema—Methylprednisolone—psoriatic arthritis	0.0033	0.00337	CcSEcCtD
Dexrazoxane—Malnutrition—Methylprednisolone—psoriatic arthritis	0.0033	0.00337	CcSEcCtD
Dexrazoxane—Breast disorder—Methotrexate—psoriatic arthritis	0.00328	0.00335	CcSEcCtD
Dexrazoxane—Malaise—Prednisolone—psoriatic arthritis	0.00324	0.00331	CcSEcCtD
Dexrazoxane—Syncope—Prednisolone—psoriatic arthritis	0.00323	0.0033	CcSEcCtD
Dexrazoxane—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00316	0.00323	CcSEcCtD
Dexrazoxane—Angiopathy—Dexamethasone—psoriatic arthritis	0.00313	0.0032	CcSEcCtD
Dexrazoxane—Angiopathy—Betamethasone—psoriatic arthritis	0.00313	0.0032	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00307	0.00314	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00306	0.00313	CcSEcCtD
Dexrazoxane—Alopecia—Dexamethasone—psoriatic arthritis	0.00305	0.00311	CcSEcCtD
Dexrazoxane—Alopecia—Betamethasone—psoriatic arthritis	0.00305	0.00311	CcSEcCtD
Dexrazoxane—Discomfort—Prednisolone—psoriatic arthritis	0.00303	0.00309	CcSEcCtD
Dexrazoxane—Haemoglobin—Prednisone—psoriatic arthritis	0.00302	0.00308	CcSEcCtD
Dexrazoxane—Haemorrhage—Prednisone—psoriatic arthritis	0.003	0.00307	CcSEcCtD
Dexrazoxane—Erythema—Betamethasone—psoriatic arthritis	0.003	0.00307	CcSEcCtD
Dexrazoxane—Erythema—Dexamethasone—psoriatic arthritis	0.003	0.00307	CcSEcCtD
Dexrazoxane—Malaise—Triamcinolone—psoriatic arthritis	0.00298	0.00305	CcSEcCtD
Dexrazoxane—Pancytopenia—Methotrexate—psoriatic arthritis	0.00298	0.00304	CcSEcCtD
Dexrazoxane—Malaise—Methylprednisolone—psoriatic arthritis	0.00298	0.00304	CcSEcCtD
Dexrazoxane—Syncope—Triamcinolone—psoriatic arthritis	0.00297	0.00303	CcSEcCtD
Dexrazoxane—Syncope—Methylprednisolone—psoriatic arthritis	0.00296	0.00302	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00295	0.00301	CcSEcCtD
Dexrazoxane—Neutropenia—Methotrexate—psoriatic arthritis	0.00293	0.00299	CcSEcCtD
Dexrazoxane—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00291	0.00297	CcSEcCtD
Dexrazoxane—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.0029	0.00296	CcSEcCtD
Dexrazoxane—Shock—Prednisolone—psoriatic arthritis	0.00289	0.00295	CcSEcCtD
Dexrazoxane—Cough—Triamcinolone—psoriatic arthritis	0.00289	0.00295	CcSEcCtD
Dexrazoxane—Myalgia—Triamcinolone—psoriatic arthritis	0.00282	0.00288	CcSEcCtD
Dexrazoxane—Pneumonia—Methotrexate—psoriatic arthritis	0.00281	0.00287	CcSEcCtD
Dexrazoxane—Myalgia—Methylprednisolone—psoriatic arthritis	0.00281	0.00287	CcSEcCtD
Dexrazoxane—Infestation NOS—Methotrexate—psoriatic arthritis	0.0028	0.00286	CcSEcCtD
Dexrazoxane—Infestation—Methotrexate—psoriatic arthritis	0.0028	0.00286	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00279	0.00285	CcSEcCtD
Dexrazoxane—Depression—Methotrexate—psoriatic arthritis	0.00279	0.00285	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00279	0.00284	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00279	0.00284	CcSEcCtD
Dexrazoxane—Discomfort—Triamcinolone—psoriatic arthritis	0.00278	0.00284	CcSEcCtD
Dexrazoxane—Discomfort—Methylprednisolone—psoriatic arthritis	0.00278	0.00284	CcSEcCtD
Dexrazoxane—Dry mouth—Triamcinolone—psoriatic arthritis	0.00275	0.00281	CcSEcCtD
Dexrazoxane—Stomatitis—Methotrexate—psoriatic arthritis	0.00273	0.00278	CcSEcCtD
Dexrazoxane—Angiopathy—Prednisone—psoriatic arthritis	0.00272	0.00278	CcSEcCtD
Dexrazoxane—Malaise—Dexamethasone—psoriatic arthritis	0.00271	0.00277	CcSEcCtD
Dexrazoxane—Malaise—Betamethasone—psoriatic arthritis	0.00271	0.00277	CcSEcCtD
Dexrazoxane—Syncope—Betamethasone—psoriatic arthritis	0.00269	0.00275	CcSEcCtD
Dexrazoxane—Syncope—Dexamethasone—psoriatic arthritis	0.00269	0.00275	CcSEcCtD
Dexrazoxane—Infection—Triamcinolone—psoriatic arthritis	0.00268	0.00274	CcSEcCtD
Dexrazoxane—Infection—Methylprednisolone—psoriatic arthritis	0.00268	0.00273	CcSEcCtD
Dexrazoxane—Shock—Triamcinolone—psoriatic arthritis	0.00266	0.00271	CcSEcCtD
Dexrazoxane—Insomnia—Prednisolone—psoriatic arthritis	0.00266	0.00271	CcSEcCtD
Dexrazoxane—Alopecia—Prednisone—psoriatic arthritis	0.00265	0.00271	CcSEcCtD
Dexrazoxane—Shock—Methylprednisolone—psoriatic arthritis	0.00265	0.00271	CcSEcCtD
Dexrazoxane—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00264	0.0027	CcSEcCtD
Dexrazoxane—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00264	0.00269	CcSEcCtD
Dexrazoxane—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00264	0.00269	CcSEcCtD
Dexrazoxane—Mental disorder—Prednisone—psoriatic arthritis	0.00263	0.00269	CcSEcCtD
Dexrazoxane—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00262	0.00267	CcSEcCtD
Dexrazoxane—Erythema—Prednisone—psoriatic arthritis	0.00261	0.00267	CcSEcCtD
Dexrazoxane—Malnutrition—Prednisone—psoriatic arthritis	0.00261	0.00267	CcSEcCtD
Dexrazoxane—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00261	0.00266	CcSEcCtD
Dexrazoxane—Myalgia—Betamethasone—psoriatic arthritis	0.00256	0.00261	CcSEcCtD
Dexrazoxane—Myalgia—Dexamethasone—psoriatic arthritis	0.00256	0.00261	CcSEcCtD
Dexrazoxane—Discomfort—Betamethasone—psoriatic arthritis	0.00253	0.00258	CcSEcCtD
Dexrazoxane—Discomfort—Dexamethasone—psoriatic arthritis	0.00253	0.00258	CcSEcCtD
Dexrazoxane—Haemoglobin—Methotrexate—psoriatic arthritis	0.00252	0.00258	CcSEcCtD
Dexrazoxane—Pain—Prednisolone—psoriatic arthritis	0.00251	0.00256	CcSEcCtD
Dexrazoxane—Haemorrhage—Methotrexate—psoriatic arthritis	0.00251	0.00256	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00246	0.00251	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00245	0.00251	CcSEcCtD
Dexrazoxane—Insomnia—Triamcinolone—psoriatic arthritis	0.00244	0.00249	CcSEcCtD
Dexrazoxane—Insomnia—Methylprednisolone—psoriatic arthritis	0.00244	0.00249	CcSEcCtD
Dexrazoxane—Infection—Betamethasone—psoriatic arthritis	0.00243	0.00249	CcSEcCtD
Dexrazoxane—Infection—Dexamethasone—psoriatic arthritis	0.00243	0.00249	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00243	0.00248	CcSEcCtD
Dexrazoxane—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00242	0.00247	CcSEcCtD
Dexrazoxane—Anaemia—Prednisone—psoriatic arthritis	0.00242	0.00247	CcSEcCtD
Dexrazoxane—Shock—Dexamethasone—psoriatic arthritis	0.00241	0.00246	CcSEcCtD
Dexrazoxane—Shock—Betamethasone—psoriatic arthritis	0.00241	0.00246	CcSEcCtD
Dexrazoxane—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00241	0.00246	CcSEcCtD
Dexrazoxane—Nervous system disorder—Betamethasone—psoriatic arthritis	0.0024	0.00245	CcSEcCtD
Dexrazoxane—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.0024	0.00245	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.0024	0.00245	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.0024	0.00245	CcSEcCtD
Dexrazoxane—Malaise—Prednisone—psoriatic arthritis	0.00236	0.00241	CcSEcCtD
Dexrazoxane—Syncope—Prednisone—psoriatic arthritis	0.00234	0.00239	CcSEcCtD
Dexrazoxane—Anorexia—Betamethasone—psoriatic arthritis	0.00234	0.00239	CcSEcCtD
Dexrazoxane—Anorexia—Dexamethasone—psoriatic arthritis	0.00234	0.00239	CcSEcCtD
Dexrazoxane—Urticaria—Prednisolone—psoriatic arthritis	0.00233	0.00238	CcSEcCtD
Dexrazoxane—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00233	0.00238	CcSEcCtD
Dexrazoxane—Fatigue—Triamcinolone—psoriatic arthritis	0.00233	0.00238	CcSEcCtD
Dexrazoxane—Fatigue—Methylprednisolone—psoriatic arthritis	0.00232	0.00237	CcSEcCtD
Dexrazoxane—Pain—Triamcinolone—psoriatic arthritis	0.00231	0.00236	CcSEcCtD
Dexrazoxane—Loss of consciousness—Prednisone—psoriatic arthritis	0.0023	0.00235	CcSEcCtD
Dexrazoxane—Angiopathy—Methotrexate—psoriatic arthritis	0.00228	0.00233	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00226	0.00231	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00223	0.00228	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00223	0.00228	CcSEcCtD
Dexrazoxane—Myalgia—Prednisone—psoriatic arthritis	0.00223	0.00227	CcSEcCtD
Dexrazoxane—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00223	0.00227	CcSEcCtD
Dexrazoxane—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00222	0.00227	CcSEcCtD
Dexrazoxane—Alopecia—Methotrexate—psoriatic arthritis	0.00222	0.00227	CcSEcCtD
Dexrazoxane—Insomnia—Dexamethasone—psoriatic arthritis	0.00222	0.00226	CcSEcCtD
Dexrazoxane—Insomnia—Betamethasone—psoriatic arthritis	0.00222	0.00226	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00221	0.00226	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.0022	0.00225	CcSEcCtD
Dexrazoxane—Discomfort—Prednisone—psoriatic arthritis	0.0022	0.00225	CcSEcCtD
Dexrazoxane—Mental disorder—Methotrexate—psoriatic arthritis	0.0022	0.00225	CcSEcCtD
Dexrazoxane—Erythema—Methotrexate—psoriatic arthritis	0.00218	0.00223	CcSEcCtD
Dexrazoxane—Malnutrition—Methotrexate—psoriatic arthritis	0.00218	0.00223	CcSEcCtD
Dexrazoxane—Urticaria—Triamcinolone—psoriatic arthritis	0.00215	0.00219	CcSEcCtD
Dexrazoxane—Urticaria—Methylprednisolone—psoriatic arthritis	0.00214	0.00219	CcSEcCtD
Dexrazoxane—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00213	0.00218	CcSEcCtD
Dexrazoxane—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00213	0.00218	CcSEcCtD
Dexrazoxane—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00213	0.00218	CcSEcCtD
Dexrazoxane—Decreased appetite—Betamethasone—psoriatic arthritis	0.00213	0.00218	CcSEcCtD
Dexrazoxane—Infection—Prednisone—psoriatic arthritis	0.00212	0.00217	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00212	0.00216	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00212	0.00216	CcSEcCtD
Dexrazoxane—Fatigue—Betamethasone—psoriatic arthritis	0.00211	0.00216	CcSEcCtD
Dexrazoxane—Fatigue—Dexamethasone—psoriatic arthritis	0.00211	0.00216	CcSEcCtD
Dexrazoxane—Shock—Prednisone—psoriatic arthritis	0.0021	0.00214	CcSEcCtD
Dexrazoxane—Pain—Betamethasone—psoriatic arthritis	0.0021	0.00214	CcSEcCtD
Dexrazoxane—Pain—Dexamethasone—psoriatic arthritis	0.0021	0.00214	CcSEcCtD
Dexrazoxane—Nervous system disorder—Prednisone—psoriatic arthritis	0.00209	0.00214	CcSEcCtD
Dexrazoxane—Skin disorder—Prednisone—psoriatic arthritis	0.00207	0.00212	CcSEcCtD
Dexrazoxane—Anorexia—Prednisone—psoriatic arthritis	0.00203	0.00208	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00203	0.00207	CcSEcCtD
Dexrazoxane—Anaemia—Methotrexate—psoriatic arthritis	0.00202	0.00206	CcSEcCtD
Dexrazoxane—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00202	0.00206	CcSEcCtD
Dexrazoxane—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00202	0.00206	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.002	0.00205	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.002	0.00205	CcSEcCtD
Dexrazoxane—Malaise—Methotrexate—psoriatic arthritis	0.00197	0.00201	CcSEcCtD
Dexrazoxane—Leukopenia—Methotrexate—psoriatic arthritis	0.00196	0.002	CcSEcCtD
Dexrazoxane—Urticaria—Dexamethasone—psoriatic arthritis	0.00195	0.00199	CcSEcCtD
Dexrazoxane—Urticaria—Betamethasone—psoriatic arthritis	0.00195	0.00199	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00194	0.00199	CcSEcCtD
Dexrazoxane—Dizziness—Prednisolone—psoriatic arthritis	0.00194	0.00198	CcSEcCtD
Dexrazoxane—Asthenia—Triamcinolone—psoriatic arthritis	0.00194	0.00198	CcSEcCtD
Dexrazoxane—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00194	0.00198	CcSEcCtD
Dexrazoxane—Abdominal pain—Betamethasone—psoriatic arthritis	0.00194	0.00198	CcSEcCtD
Dexrazoxane—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00194	0.00198	CcSEcCtD
Dexrazoxane—Body temperature increased—Betamethasone—psoriatic arthritis	0.00194	0.00198	CcSEcCtD
Dexrazoxane—Asthenia—Methylprednisolone—psoriatic arthritis	0.00193	0.00197	CcSEcCtD
Dexrazoxane—Insomnia—Prednisone—psoriatic arthritis	0.00193	0.00197	CcSEcCtD
Dexrazoxane—Pruritus—Triamcinolone—psoriatic arthritis	0.00191	0.00195	CcSEcCtD
Dexrazoxane—Cough—Methotrexate—psoriatic arthritis	0.00191	0.00195	CcSEcCtD
Dexrazoxane—Pruritus—Methylprednisolone—psoriatic arthritis	0.00191	0.00195	CcSEcCtD
Dexrazoxane—Myalgia—Methotrexate—psoriatic arthritis	0.00186	0.0019	CcSEcCtD
Dexrazoxane—Decreased appetite—Prednisone—psoriatic arthritis	0.00185	0.00189	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00185	0.00189	CcSEcCtD
Dexrazoxane—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00184	0.00188	CcSEcCtD
Dexrazoxane—Fatigue—Prednisone—psoriatic arthritis	0.00184	0.00188	CcSEcCtD
Dexrazoxane—Headache—Prednisolone—psoriatic arthritis	0.00184	0.00188	CcSEcCtD
Dexrazoxane—Discomfort—Methotrexate—psoriatic arthritis	0.00184	0.00188	CcSEcCtD
Dexrazoxane—Constipation—Prednisone—psoriatic arthritis	0.00182	0.00186	CcSEcCtD
Dexrazoxane—Dizziness—Triamcinolone—psoriatic arthritis	0.00179	0.00182	CcSEcCtD
Dexrazoxane—Dizziness—Methylprednisolone—psoriatic arthritis	0.00178	0.00182	CcSEcCtD
Dexrazoxane—Infection—Methotrexate—psoriatic arthritis	0.00177	0.00181	CcSEcCtD
Dexrazoxane—Feeling abnormal—Prednisone—psoriatic arthritis	0.00176	0.0018	CcSEcCtD
Dexrazoxane—Asthenia—Betamethasone—psoriatic arthritis	0.00176	0.0018	CcSEcCtD
Dexrazoxane—Asthenia—Dexamethasone—psoriatic arthritis	0.00176	0.0018	CcSEcCtD
Dexrazoxane—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00175	0.00179	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00175	0.00178	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00174	0.00178	CcSEcCtD
Dexrazoxane—Nausea—Prednisolone—psoriatic arthritis	0.00174	0.00178	CcSEcCtD
Dexrazoxane—Pruritus—Dexamethasone—psoriatic arthritis	0.00173	0.00177	CcSEcCtD
Dexrazoxane—Pruritus—Betamethasone—psoriatic arthritis	0.00173	0.00177	CcSEcCtD
Dexrazoxane—Skin disorder—Methotrexate—psoriatic arthritis	0.00173	0.00177	CcSEcCtD
Dexrazoxane—Vomiting—Triamcinolone—psoriatic arthritis	0.00172	0.00175	CcSEcCtD
Dexrazoxane—Vomiting—Methylprednisolone—psoriatic arthritis	0.00171	0.00175	CcSEcCtD
Dexrazoxane—Anorexia—Methotrexate—psoriatic arthritis	0.0017	0.00174	CcSEcCtD
Dexrazoxane—Urticaria—Prednisone—psoriatic arthritis	0.0017	0.00173	CcSEcCtD
Dexrazoxane—Headache—Triamcinolone—psoriatic arthritis	0.00169	0.00173	CcSEcCtD
Dexrazoxane—Headache—Methylprednisolone—psoriatic arthritis	0.00169	0.00172	CcSEcCtD
Dexrazoxane—Body temperature increased—Prednisone—psoriatic arthritis	0.00169	0.00172	CcSEcCtD
Dexrazoxane—Abdominal pain—Prednisone—psoriatic arthritis	0.00169	0.00172	CcSEcCtD
Dexrazoxane—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00168	0.00171	CcSEcCtD
Dexrazoxane—Diarrhoea—Betamethasone—psoriatic arthritis	0.00168	0.00171	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00162	0.00166	CcSEcCtD
Dexrazoxane—Dizziness—Dexamethasone—psoriatic arthritis	0.00162	0.00165	CcSEcCtD
Dexrazoxane—Dizziness—Betamethasone—psoriatic arthritis	0.00162	0.00165	CcSEcCtD
Dexrazoxane—Insomnia—Methotrexate—psoriatic arthritis	0.00161	0.00165	CcSEcCtD
Dexrazoxane—Nausea—Triamcinolone—psoriatic arthritis	0.0016	0.00164	CcSEcCtD
Dexrazoxane—Nausea—Methylprednisolone—psoriatic arthritis	0.0016	0.00163	CcSEcCtD
Dexrazoxane—Dyspnoea—Methotrexate—psoriatic arthritis	0.00159	0.00162	CcSEcCtD
Dexrazoxane—Somnolence—Methotrexate—psoriatic arthritis	0.00159	0.00162	CcSEcCtD
Dexrazoxane—Vomiting—Dexamethasone—psoriatic arthritis	0.00156	0.00159	CcSEcCtD
Dexrazoxane—Vomiting—Betamethasone—psoriatic arthritis	0.00156	0.00159	CcSEcCtD
Dexrazoxane—Decreased appetite—Methotrexate—psoriatic arthritis	0.00155	0.00158	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00154	0.00157	CcSEcCtD
Dexrazoxane—Fatigue—Methotrexate—psoriatic arthritis	0.00154	0.00157	CcSEcCtD
Dexrazoxane—Headache—Betamethasone—psoriatic arthritis	0.00153	0.00157	CcSEcCtD
Dexrazoxane—Headache—Dexamethasone—psoriatic arthritis	0.00153	0.00157	CcSEcCtD
Dexrazoxane—Asthenia—Prednisone—psoriatic arthritis	0.00153	0.00156	CcSEcCtD
Dexrazoxane—Pain—Methotrexate—psoriatic arthritis	0.00152	0.00156	CcSEcCtD
Dexrazoxane—Pruritus—Prednisone—psoriatic arthritis	0.00151	0.00154	CcSEcCtD
Dexrazoxane—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00147	0.0015	CcSEcCtD
Dexrazoxane—Diarrhoea—Prednisone—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Dexrazoxane—Nausea—Dexamethasone—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Dexrazoxane—Nausea—Betamethasone—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Dexrazoxane—Urticaria—Methotrexate—psoriatic arthritis	0.00142	0.00145	CcSEcCtD
Dexrazoxane—Dizziness—Prednisone—psoriatic arthritis	0.00141	0.00144	CcSEcCtD
Dexrazoxane—Body temperature increased—Methotrexate—psoriatic arthritis	0.00141	0.00144	CcSEcCtD
Dexrazoxane—Abdominal pain—Methotrexate—psoriatic arthritis	0.00141	0.00144	CcSEcCtD
Dexrazoxane—Vomiting—Prednisone—psoriatic arthritis	0.00136	0.00139	CcSEcCtD
Dexrazoxane—Headache—Prednisone—psoriatic arthritis	0.00134	0.00137	CcSEcCtD
Dexrazoxane—Asthenia—Methotrexate—psoriatic arthritis	0.00128	0.00131	CcSEcCtD
Dexrazoxane—Nausea—Prednisone—psoriatic arthritis	0.00127	0.00129	CcSEcCtD
Dexrazoxane—Pruritus—Methotrexate—psoriatic arthritis	0.00126	0.00129	CcSEcCtD
Dexrazoxane—Diarrhoea—Methotrexate—psoriatic arthritis	0.00122	0.00125	CcSEcCtD
Dexrazoxane—Dizziness—Methotrexate—psoriatic arthritis	0.00118	0.0012	CcSEcCtD
Dexrazoxane—Vomiting—Methotrexate—psoriatic arthritis	0.00113	0.00116	CcSEcCtD
Dexrazoxane—Headache—Methotrexate—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Dexrazoxane—Nausea—Methotrexate—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
